51 Labs Expands Sports Nutrition
Line with Five New Innovative Products
Company in final phase of name and
ticker symbol change
MELBOURNE, FL --
February 10, 2025 -- InvestorsHub NewsWire -- 51
Labs, a wholly owned subsidiary of Fifty 1 Labs, Inc., a dynamic
company active in the sports supplement, fitness equipment, and
health and wellness sectors, is excited to announce the launch of
five new products in the sports nutrition market. This expansion
reinforces 51 Labs' commitment to delivering high-quality,
performance-enhancing supplements that support active and
health-conscious consumers.
The new products include:
-
ION+ Select Electrolyte
Formula – Designed to
optimize hydration and electrolyte balance, ION+ Select supports
endurance and recovery for athletes and active individuals. This
advanced formula replenishes essential minerals lost through sweat,
ensuring peak performance during intense
workouts.
-
Nature's Expresso
Coffee – A premium,
organic coffee blend crafted to provide a natural energy boost.
Rich in antioxidants and caffeine, Nature's Expresso supports
mental clarity, focus, and sustained energy without the crash
associated with artificial stimulants.
-
Turmeric Gummies
– Packed with curcumin, the
active compound in turmeric, these gummies promote joint health,
reduce inflammation, and support overall wellness. Ideal for
athletes looking to maintain mobility and
recovery.
-
Apple Cider
Gummies – Harnessing the
benefits of apple cider vinegar, these gummies aid digestion, boost
metabolism, and support weight management. A convenient and tasty
way to incorporate apple cider vinegar into a daily
routine.
-
Ashwagandha
Gummies – Known for its
adaptogenic properties, Ashwagandha helps reduce stress, enhance
endurance, and support overall mental and physical well-being.
These gummies are perfect for those looking to balance energy
levels and recover from daily stressors.
Complementing the 51 Labs
Product Line
These new additions perfectly
complement 51 Labs' existing portfolio of sports supplements and
wellness products. With a focus on high-quality ingredients and
scientifically backed formulations, these products enhance the
company's commitment to providing holistic solutions for athletes,
fitness enthusiasts, and health-conscious individuals.
"Our goal at 51 Labs is to continuously innovate
and provide our customers with products that enhance their
performance, recovery, and overall health," stated Robert Clark,
CEO of Fifty 1 Labs, Inc. "With these new launches, we are
expanding our reach in the sports nutrition market while
maintaining our commitment to quality and efficacy."
Regulatory and Corporate
Updates
In addition to its product expansion,
51 Labs has successfully completed all questions from the Financial
Industry Regulatory Authority (FINRA) and is now in the final phase
of the process for its name and ticker symbol change. This
milestone marks a significant step forward in the company's
corporate growth strategy, aligning its branding with its long-term
vision and market positioning.
Furthermore, FINRA has responded to the company's
request to regain its 15c211 with comments, and the company has
promptly addressed those comments. The reinstatement of the 15c211
is a critical step in restoring full trading capabilities,
increasing market transparency, and enhancing liquidity for
investors. This development represents a major milestone in
positioning the company for future growth and ensuring
accessibility for a broader investor base.
Availability and Additional
Information
The new products will be available in
the coming weeks for purchase through the Company's website at
https://get51fit.com. For more information on these
products and other offerings from 51 Labs, please visit the
Company's website.
For more information, please visit https://fifty1labs.com/.
About Fifty 1 Labs,
Inc.
Consumer Automotive Finance, Inc. (OTCPK:
CAFI), soon to be renamed Fifty 1 Labs, Inc., is a publicly
traded company focused on sports supplementation, fitness
equipment, and holistic wellness. The company operates four key
subsidiaries: 51, LLC, which specializes in sports supplements; The
Quickness, which offers patented athletic training equipment;
Astound NMN, a leader in anti-aging and DNA repair supplements; and
Drago Knives, patented knife throwing technology. Fifty 1 Labs,
Inc. is also actively pursuing strategic acquisitions to expand its
portfolio and drive sustainable growth.
Safe Harbor Statement:
The information provided in this release may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Identifiable by
words such as "may," "will," "should," "plans," "expects,"
"anticipates," "continue," "estimate," "project," "intend," and
similar expressions, these statements may also be made in written
or oral form in the company's filings with the U.S. Securities and
Exchange Commission, OTC Markets, press releases, other written
materials, or in oral statements made by its officers, directors,
or employees to third parties. There can be no assurance that such
statements will prove to be accurate. The company cautions that
these forward-looking statements are further qualified by other
factors including, but not limited to, those set forth in the
company's Disclosure Statements. Forward-looking statements involve
risks and uncertainties that could cause actual results to differ
materially from those projected or anticipated. These risks and
uncertainties include, but are not limited to, general economic and
business conditions, effects of continued geopolitical unrest and
regional conflicts, competition, changes in technology and methods
of marketing, delays in completing various engineering and
manufacturing programs, changes in customer order patterns, changes
in product mix, continued success in technological advances and
delivering technological innovations, shortages in components,
production delays due to performance quality issues with outsourced
components, and various other factors beyond the company's control.
The company does not undertake any obligation to update publicly or
to revise any statements in this release, whether as a result of
new information, future events, or otherwise.
Investor Relations Contact:
Investor Relations
877-814-4188
ir@fifty1labs.com
